Your browser doesn't support javascript.
loading
Network controllability solutions for computational drug repurposing using genetic algorithms.
Popescu, Victor-Bogdan; Kanhaiya, Krishna; Nastac, Dumitru Iulian; Czeizler, Eugen; Petre, Ion.
Afiliação
  • Popescu VB; Computer Science, Åbo Akademi University, 20500, Turku, Finland.
  • Kanhaiya K; Computer Science, Åbo Akademi University, 20500, Turku, Finland.
  • Nastac DI; POLITEHNICA University of Bucharest, Faculty of Electronics, Telecommunications and Information Technology, 061071, Bucharest, Romania.
  • Czeizler E; Computer Science, Åbo Akademi University, 20500, Turku, Finland.
  • Petre I; National Institute for Research and Development in Biological Sciences, 060031, Bucharest, Romania.
Sci Rep ; 12(1): 1437, 2022 01 26.
Article em En | MEDLINE | ID: mdl-35082323
ABSTRACT
Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximize its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We demonstrate our algorithm on several cancer networks and on several random networks with their edges distributed according to the Erdos-Rényi, the Scale-Free, and the Small World properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Pancreáticas / Algoritmos / Neoplasias da Mama / Reposicionamento de Medicamentos / Proteínas de Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Pancreáticas / Algoritmos / Neoplasias da Mama / Reposicionamento de Medicamentos / Proteínas de Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article